AGN 6.08% 78.5¢ argenica therapeutics limited

Economic cost of stroke 2024 report, page-3

  1. 46 Posts.
    lightbulb Created with Sketch. 21
    I think you're right about the chances of approval once there is efficacy proven.The report states we are spending a lot in the first 12 months after stroke (about $175k per person).

    Most of the costs in the table below will be spent regardless of outcome. We are investing a lot in the health response to stroke so a mechanism that can deliver a pay off for patients and their families and potentially get younger people back to work post stroke would be compelling for governments.


    https://hotcopper.com.au/data/attachments/6496/6496234-e428c8e13736b7d2cebf4a109f79e23b.jpg
 
watchlist Created with Sketch. Add AGN (ASX) to my watchlist
(20min delay)
Last
78.5¢
Change
0.045(6.08%)
Mkt cap ! $100.5M
Open High Low Value Volume
76.0¢ 78.5¢ 74.0¢ $41.70K 55.59K

Buyers (Bids)

No. Vol. Price($)
1 5633 75.5¢
 

Sellers (Offers)

Price($) Vol. No.
78.5¢ 1336 1
View Market Depth
Last trade - 16.10pm 31/10/2024 (20 minute delay) ?
AGN (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.